Skip to Main Content

Paper Details

Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop.
Am J Prev Cardiol
10
2022
CVD, Human, cardiovascular disease, cardiovascular diseases, coronary atherosclerosis
Author NameAffiliation
Ann Marie NavarUniversity of Texas Southwestern Medical Center
Walter T AmbrosiusWake Forest University School of Medicine
Pamela S DouglasDuke University
Amit KheraCenter for Genomic Medicine, Massachusetts General Hospital
Amit Khera
Donald M Lloyd-JonesNorthwestern University
Daniel Mu??ozVanderbilt University Medical Center
Khurram Nasir
Paul M RidkerCenter for Cardiovascular Disease Prevention, Brigham and Women's Hospital
Jennifer G RobinsonUniversity of Iowa
  • 1 - 10

Datasets

Release 1.2